|
BLRX
BioLineRx Ltd.
BLRX · Q2 FY2023
|
Q2 FY2023 |
|
BLRX Q2 FY2023 transcript
|
|
CUE
Cue Biopharma, Inc.
CUE · Q2 FY2023
|
Q2 FY2023 |
|
CUE Q2 FY2023 transcript
|
|
WFG
West Fraser Timber Co., Ltd
WFG · Q2 FY2023
|
Q2 FY2023 |
|
WFG Q2 FY2023 transcript
|
|
IMPP
Imperial Petroleum Inc./Marshall Islands
IMPP · Q2 FY2023
|
Q2 FY2023 |
|
IMPP Q2 FY2023 transcript
|
|
SAN
Banco Santander, S.A.
SAN · Q2 FY2023
|
Q2 FY2023 |
|
SAN Q2 FY2023 transcript
|
|
GRWG
GrowGeneration Corp.
GRWG · Q2 FY2023
|
Q2 FY2023 |
|
GRWG Q2 FY2023 transcript
|
|
THCH
TH International Ltd
THCH · Q2 FY2023
|
Q2 FY2023 |
|
THCH Q2 FY2023 transcript
|
|
USEA
United Maritime Corp
USEA · Q2 FY2023
|
Q2 FY2023 |
|
USEA Q2 FY2023 transcript
|
|
BABA
Alibaba Group Holding Ltd
BABA · Q1 FY2024
|
Q1 FY2024 |
|
BABA Q1 FY2024 transcript
|
|
AESI
Atlas Energy Solutions Inc.
AESI · Q2 FY2023
|
Q2 FY2023 |
|
AESI Q2 FY2023 transcript
|
|
YQ
17 Education & Technology Group Inc.
YQ · Q2 FY2023
|
Q2 FY2023 |
|
YQ Q2 FY2023 transcript
|
|
GASS
StealthGas Inc.
GASS · Q2 FY2023
|
Q2 FY2023 |
|
GASS Q2 FY2023 transcript
|
|
HTHT
H World Group Ltd
HTHT · Q2 FY2023
|
Q2 FY2023 |
|
HTHT Q2 FY2023 transcript
|
|
AROC
Archrock, Inc.
AROC · Q2 FY2023
|
Q2 FY2023 |
|
AROC Q2 FY2023 transcript
|
|
PHG
Koninklijke Philips NV
PHG · Q2 FY2023
|
Q2 FY2023 |
|
PHG Q2 FY2023 transcript
|
|
BIPH
Brookfield Infrastructure Partners L.P.
BIPH · Q2 FY2023
|
Q2 FY2023 |
|
BIPH Q2 FY2023 transcript
|
|
YI
111, Inc.
YI · Q2 FY2023
|
Q2 FY2023 |
|
YI Q2 FY2023 transcript
|
|
CUB
Lionheart Holdings
CUB · Q2 FY2023
|
Q2 FY2023 |
|
CUB Q2 FY2023 transcript
|
|
SSYS
Stratasys Ltd.
SSYS · Q2 FY2023
|
Q2 FY2023 |
|
SSYS Q2 FY2023 transcript
|
|
EIC
Eagle Point Income Co Inc.
EIC · Q2 FY2023
|
Q2 FY2023 |
|
EIC Q2 FY2023 transcript
|
|
NOAH
Noah Holdings Ltd
NOAH · Q2 FY2023
|
Q2 FY2023 |
|
NOAH Q2 FY2023 transcript
|
|
TOUR
Tuniu Corp
TOUR · Q2 FY2023
|
Q2 FY2023 |
|
TOUR Q2 FY2023 transcript
|
|
GGB
Gerdau S.A.
GGB · Q2 FY2023
|
Q2 FY2023 |
|
GGB Q2 FY2023 transcript
|
|
LKFT
Lakefront Biotherapeutics NV
LKFT · Q2 FY2023
|
Q2 FY2023 |
|
LKFT Q2 FY2023 transcript
|